GE HealthCare Technologies (NASDAQ:GEHC) Price Target Raised to $97.00

GE HealthCare Technologies (NASDAQ:GEHC) had its target price lifted by Wells Fargo & Company from $95.00 to $97.00 in a report issued on Thursday morning,Benzinga reports. The firm currently has an overweight rating on the stock.

GEHC has been the topic of several other reports. Jefferies Financial Group upped their target price on GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a report on Thursday, December 11th. Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Monday, December 29th. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $98.00 price objective on shares of GE HealthCare Technologies in a research note on Friday, January 9th. Bank of America boosted their target price on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a report on Monday, January 5th. Finally, BTIG Research upped their price target on shares of GE HealthCare Technologies from $87.00 to $91.00 and gave the company a “buy” rating in a research report on Wednesday. Seven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of “Hold” and an average target price of $92.50.

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock opened at $80.65 on Thursday. The stock has a market cap of $36.76 billion, a price-to-earnings ratio of 17.69, a P/E/G ratio of 2.38 and a beta of 1.08. GE HealthCare Technologies has a twelve month low of $57.65 and a twelve month high of $94.80. The company’s fifty day moving average is $82.73 and its 200 day moving average is $77.55. The company has a quick ratio of 0.95, a current ratio of 1.37 and a debt-to-equity ratio of 0.91.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The business had revenue of $5.70 billion during the quarter, compared to analyst estimates of $5.60 billion. During the same period last year, the company earned $1.45 EPS. GE HealthCare Technologies’s revenue for the quarter was up 7.1% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Sell-side analysts forecast that GE HealthCare Technologies will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, January 9th. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.07%.

Hedge Funds Weigh In On GE HealthCare Technologies

A number of hedge funds have recently added to or reduced their stakes in GEHC. Wedge Capital Management L L P NC purchased a new position in shares of GE HealthCare Technologies in the third quarter valued at $26,859,000. Valicenti Advisory Services Inc. raised its stake in GE HealthCare Technologies by 22.6% during the third quarter. Valicenti Advisory Services Inc. now owns 68,107 shares of the company’s stock valued at $5,115,000 after purchasing an additional 12,550 shares in the last quarter. Locust Wood Capital Advisers LLC lifted its position in GE HealthCare Technologies by 7.1% during the third quarter. Locust Wood Capital Advisers LLC now owns 2,084,337 shares of the company’s stock valued at $156,534,000 after purchasing an additional 137,992 shares during the last quarter. Nan Fung Trinity HK Ltd. bought a new position in GE HealthCare Technologies during the third quarter valued at $23,206,000. Finally, National Bank of Canada FI grew its stake in shares of GE HealthCare Technologies by 133.3% in the 2nd quarter. National Bank of Canada FI now owns 899,693 shares of the company’s stock worth $66,640,000 after buying an additional 514,007 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.